-
Product Insights
Medical Imaging Information Systems Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Medical Imaging Information Systems Pipeline Market Report Overview Medical imaging information systems are used in hospitals and diagnostic imaging centers to store, retrieve, modify, and forward images and information to hospital departments or imaging centers over a network. The Medical Imaging Information Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress,...
-
Product Insights
Kuolavaara-Keulakkopaa
Kuolavaara-Keulakkopaa is an Onshore Wind project located in Lapland, Finland. The project is owned by Allianz Capital Partners GmbH and was developed by Impax Asset Management Group Plc; Metsahallitus. The project came online in 2016. Empower your strategies with our Kuolavaara-Keulakkopaa report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
Glanaruddery Wind Farm
Glanaruddery Wind Farm is an Onshore Wind project located in Kerry, Ireland. The project is owned by Greencoat Renewables PLC and was developed by Impax Asset Management Group Plc; Saorgus Energy Ltd. The project came online in 2018. Empower your strategies with our Glanaruddery Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
El Calaveron Solar Park
El Calaveron Solar Park is a solar PV project located in Castile-La Mancha, Spain. The project is owned by Impax New Energy Investors II (GP) Ltd and was developed by Epuron Holding GmbH & Co. KG (Inactive). The project came online in 2008. Empower your strategies with our El Calaveron Solar Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3...
-
Product Insights
Endoscopy Visualization Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Endoscopy Visualization Systems Pipeline Market Report Overview Endoscopy Visualization Systems aid in the visualization and interpretation of endoscopic images. The Endoscopy Visualization Systems pipeline market research report provides comprehensive information about the Endoscopy Visualization Systems pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Territories · The US · Europe · Japan · India · Israel · Brazil · China · South Korea Key...
-
Product Insights
Impax – Lettergull Wind Farm 20 MW – Ulster
Equip yourself with the essential tools needed to make informed and profitable decisions with our Impax - Lettergull Wind Farm 20 MW - Ulster report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Benign Prostatic Hyperplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The symptoms of Benign Prostatic Hyperplasia (BPH) include decreased strength of the urine stream, dribbling after urination, pain during urination, waking at night to urinate, and difficulty starting a urine stream. The Benign Prostatic Hyperplasia pipeline drugs market research report provides comprehensive information on the therapeutics under development for Benign Prostatic Hyperplasia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action...
-
Product Insights
Urinary Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder’s contents, or it may just cause minor leakage. Symptoms include stress incontinence, rashes, and other skin disorders. Risk factors include age, gender, overweight, smoking, and other kidney diseases. Treatment includes anticholinergics and topical estrogen. The Urinary Incontinence drugs in development market research report provide comprehensive information on the therapeutics under development for Urinary Incontinence, complete with analysis...
-
Sector Analysis
Parkinson’s Disease: Global Drug Forecast and Market Analysis to 2026
Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors such as aging, environmental factors/exposures, and genetic predispositions. Current treatments centre on the management of dopamine levels in the brain, with levodopa-based therapies remaining the standard of care in the Parkinson’s market for the past...
-
Sector Analysis
PharmaPoint: Migraine – Global Drug Forecast and Market Analysis to 2026
Migraine is a complex neurological condition, characterized by frequent headaches that can last between four and 72 hours. The pain is often unilateral and pulsating in nature, which can often be worsened by physical activity. In most cases, migraine is associated with symptoms such as photophobia, phonophobia, osmophobia, nausea, vomiting, loss of appetite, and sometimes sensory disturbances. The market is currently split into acute and preventative segments, with the majority of drugs used in treatment genericized across the 7MM (US,...